Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2004
04/22/2004WO2003078649A3 Methods to increase nucleotide signals by raman scattering
04/22/2004WO2003077729A9 Methods and compositions for identifying and characterizing hepatitis c
04/22/2004WO2003075751A3 Overfeeding methods for determining therapeutic strategies and/or targets for obesity therapeutics
04/22/2004WO2003070965A8 The eaat2 promoter and uses thereof
04/22/2004WO2003066870A3 Method for detecting polymorphisms in nucleic acids
04/22/2004WO2003062784A3 Apparatus and methods for monitoring the status of a metabolically active cell
04/22/2004WO2003062471A9 Model cell systems for screening of anti-hypertrophic therapeutics
04/22/2004WO2003060084A9 Methods for making polynucleotides and purifying double-stranded polynucleotides
04/22/2004WO2003057916A3 Cancer profiles
04/22/2004WO2003055994A9 Hxhv virus, nucleic material, peptide material and uses
04/22/2004WO2003040400A8 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids
04/22/2004WO2003040345A3 Type 2 cytokine receptor and nucleic acids encoding same
04/22/2004WO2003038130A8 Therapeutics and diagnostics for disorders of erythropoiesis
04/22/2004WO2003035897A3 Enzyme substrates for detecting beta-d-ribofuranosidase activity
04/22/2004WO2003035896A3 Chromogenic enzyme substrates and method for detecting beta-d-ribofuranosidase activity
04/22/2004WO2003034896A3 Methods of diagnosis of autoimmune disease
04/22/2004WO2003033738A3 Polymorphic marker that can be used to assess the efficacy of interferon therapy
04/22/2004WO2003029428A8 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
04/22/2004WO2002102846A3 Pharmaceutical composition for diagnosis, prevention or treatment of a tumorous state, comprising a modulator of the actin polymerisation state
04/22/2004WO2002101090A3 Method for determining the existence of animal or vegetable mixtures in organic substrates
04/22/2004WO2002092782A3 Diagnosis and treatment of malignant neoplasms
04/22/2004WO2002090577A3 Positive response biosensors and other sensors
04/22/2004WO2002090567A3 Sperm-specific cation channel, and uses therefor
04/22/2004WO2002086163A8 Methods for high throughput genome analysis using restriction site tagged microarrays
04/22/2004WO2002064731A9 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
04/22/2004WO2002022858A9 Id-1 and id-2 genes and products as diagnostic and prognostic markers and therapeutic targets for treatment of breast cancer and other types of carcinoma
04/22/2004WO1990005910A3 Wholly microfabricated biosensors and process for the manufacture and use thereof
04/22/2004US20040078849 Modulating developmental transitions in plants
04/22/2004US20040078834 Transgenic animal whose genome has a transcriptional regulatory sequence capable of directing expression to b-cells linked to a dna sequence encoding t-cell leukemias
04/22/2004US20040078833 Mutations in and genomic structure of herg - along QT syndrome gene
04/22/2004US20040078149 Method of reducing analysis time of endpoint-type reaction profiles
04/22/2004US20040078148 Site-directed mutagenesis; green fluorescent proteins; fusion proteins
04/22/2004US20040077933 Method and system for detecting radiation from wireless communication devices employing microorganisms
04/22/2004US20040077847 Nucleic acid encoding a pneumoccocal surface protein c gene or epitope
04/22/2004US20040077837 Microtubule-associated proteins and tubulins
04/22/2004US20040077833 Regulation of human mrp5-like protein
04/22/2004US20040077832 Jfy1protein induces rapid apoptosis
04/22/2004US20040077826 Randomly generated glycopeptide combinatorial libraries
04/22/2004US20040077613 Stimulation of preadipocyte differentiation; insulin resis-tance syndrome, dyslipidemia, type 2 diabetes; LXR alpha receptor agonists
04/22/2004US20040077611 Triple therapy of angiotensin converting enzyme inhibitor epoxy-steroidal aldosterone antagonist and diuretic or digoxin for treatment of cardiovascular disease
04/22/2004US20040077581 Long chain fatty acid coA synthetase activity; polynucleotide encoding amino acid sequence 2
04/22/2004US20040077547 Preventing catalytic conversion of factors X, VII AND IX to Xa, VIIa and IXa respectively
04/22/2004US20040077524 Method for selectively inhibiting fungal growth
04/22/2004US20040077100 Fluorescence polarization assay
04/22/2004US20040077080 Compositions and methods for induction of proteins involved in xenobiotic metabolism
04/22/2004US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders
04/22/2004US20040077075 Microfermentors for rapid screening and analysis of biochemical processes
04/22/2004US20040077074 Multi-chambered analysis device
04/22/2004US20040077066 Purified active HCV NS2/3 protease
04/22/2004US20040077064 Identification and isolation of novel DNA and to the recombinant production of novel polypeptides
04/22/2004US20040077058 Domains of geldanamycin and herbimycin polyketide synthases, polynucleotides that encode such enzymes, and to host cells in which such encoding polynucleotides can be advantageously expressed
04/22/2004US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
04/22/2004US20040077046 Histone deacetylase-related gene and protein
04/22/2004US20040077045 Melanoma Associated antigen (MAGE) tumor associated genes, nucleic acids encoding such peptides and antibodies relating thereto; Human Leukocyte Antigen (HLA)
04/22/2004US20040077031 Using the manganese form of the enzyme and therefore, the advantage of identifying potent inhibitors that might not show activity in cellular systems because the wrong metal cofactor is used
04/22/2004US20040077030 Methods and kits for detecting protein kinases
04/22/2004US20040077024 Method of reversibly disrupting a conjugate comprising a biotin compound and a biotin compound
04/22/2004US20040077023 By measuring levels of antibodies to glycans in a biological sample
04/22/2004US20040077020 Diagnostic microarray for inflammatory bowel disease, crohn's disease and ulcerative colitis
04/22/2004US20040077016 The bacteria are good research materials for investigating the interrelation between enzyme structures and functions since they are stable at extreme pH, crystallize easily and are easy- to-handle
04/22/2004US20040077015 Detection of Mycoplasma in patients with chronic fatigue syndrome and related disorders
04/22/2004US20040077014 Kit for enhancing the association rates of polynucleotides
04/22/2004US20040077012 Thermostable DNA polymerases that can serve as chromosomal replicases and are derived from thermophilic bacteria
04/22/2004US20040077011 Novel human gene relating to respiratory diseases and obesity
04/22/2004US20040077009 Human cyclin-dependent kinase (hPNQALRE)
04/22/2004US20040077008 Method and compositions for reversible inhibition of thermostable polymerases
04/22/2004US20040077007 Human SMN-like protein
04/22/2004US20040077005 Novel topoisomerase IV, corresponding nucleotide sequences and uses thereof
04/22/2004US20040077004 Methods, kits and systems that use nucleotide analogs to confer increased accuracy and improved resolution in the analysis and sequencing of oligonucleotide mixtures
04/22/2004US20040077003 Composition for the detection of blood cell and immunological response gene expression
04/22/2004US20040077001 Use for carboxypeptidase-A4 in the diagnosis and treatment of metabolic disorders
04/22/2004US20040077000 Using cynomologous monkey P-glycoprotein nucleic acids and polypeptides in determining bioavailability of drugs and for screening for inhibitors of cynomologous P-glycoprotein
04/22/2004US20040076999 Computer user interface facilitating acquiring and analyzing of biological specimen traits
04/22/2004US20040076998 Sequencing method using magnifying tags
04/22/2004US20040076997 Determining the risk of metastasis of a breast or colon tumor, which involve determining whether a tissue sample from a tumor expresses a polypeptide encoded by a gene SEQ ID NOS:1-18
04/22/2004US20040076996 Useful as a fully automatic gene analysis/diagnosis device which can be simplified in structure, made compact in size and light in weight, cheap and in which detection of various kinds of DNA can be conducted rapidly and with precision
04/22/2004US20040076995 Finding that the Nurr1 transciption factor, which forms a heterodimer with the retinoid X receptor, can be mutated in the I box region such that dimerisation does not occur while Nurr1 transcriptional activation activity is retained
04/22/2004US20040076994 Method of detecting target nucleic acid and nucleic acid probe
04/22/2004US20040076990 Universal method and composition for the rapid lysis of cells for the release of nucleic acids and their detection
04/22/2004US20040076988 Method of haplotype-based genetic analysis for determining risk for developing insulin resistance, coronary artery disease and other phenotypes
04/22/2004US20040076987 Methods for testing the effect of various conditions on oligonucleotide arrays before, during or after production
04/22/2004US20040076986 A gene and/or a protein involved in the prevention or treatment of allergic diseases and dermatitis
04/22/2004US20040076985 Reagents which regulate human chemokine-like receptor and reagents which bind to human chemokine-like receptor gene products, useful in preventing, ameliorating, or correcting dysfunctions or diseases including HIV infection,
04/22/2004US20040076983 Ligand detection method
04/22/2004US20040076981 Fungal gene cluster associated with pathogenesis
04/22/2004US20040076978 Method to identify genes associated with chronic myelogenous leukemia
04/22/2004US20040076977 Marker assisted selection of bovine for improved milk production using diacylglycerol acyltransferase gene dgat1
04/22/2004US20040076975 Methods for assessing the risk of non-insulin-dependent diabetes mellitus based on allelic variations in the 5'-flanking region of the insulin gene and body fat
04/22/2004US20040076974 Liver necrosis predictive genes
04/22/2004US20040076972 Marking
04/22/2004US20040076971 UV excitable fluorescent energy transfer dyes
04/22/2004US20040076969 Method for detecting known mutations in tube
04/22/2004US20040076968 Method for detecting pre-disposition to hepatotoxicity
04/22/2004US20040076964 Methods for in situ generation of nucleic acid arrays
04/22/2004US20040076962 Useful for detecting hepatocellular carcinoma, metastasis and tumor recurrence
04/22/2004US20040076961 Biomolecule retaining material and methods for attaching biomolecules to a surface
04/22/2004US20040076960 Determining the presence or absence of a disease-predisposing haplotype containing a JW1 variant allele at the NOD2/CARD15 locus the presence of which is diagnostic of or predictive of susceptibility to Crohn's disease.
04/22/2004US20040076959 Methods and systems for polynucleotide detection
04/22/2004US20040076957 Hybridized array analysis aiding method and analysis aiding service
04/22/2004US20040076956 Oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence; ascertaining genetic and/ or epigenetic parameters of DNA repair genes